
Opinion|Videos|July 10, 2024
Factors Influencing Treatment Choice in Spasticity
A panel of experts discuss variation in spasticity between patients and the role disease severity can play.
Advertisement
Episodes in this series

- Discuss the variation in spasticity presentation among patients and within the same patient.
- How do you factor in this variability when recommending treatments?
- What roles do disease severity, anatomical distribution, and comorbidities play in choosing among different options?
- How important is it to understand triggers of spasticity or underlying disability causes when managing moderate/severe spasticity?
Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Cladribine Tablets Show Ability to Improve or Stabilize Cognitive Function in Patients With Relapsing Multiple Sclerosis
2
Cladribine Maintains Efficacy, Safety Profile in Older Patients With Multiple Sclerosis
3
Myelin Protective Small Molecule Lucid-MS Shows Promising Early-Stage Data in Healthy Volunteers
4
CD40L Inhibitor Frexalimab Enters Phase 3 FREXITE Trial of Non-Relapsing Secondary Progressive Multiple Sclerosis
5











